NCT06892886

Brief Summary

Stroke produces brain damages that results in sensory, motor, and cognitive impairments which reduce the patient's quality of life and social participation. Upper limb recovery is a complex process whose goal is to allow the patients to gain, in part or completely, independence in daily living activities, for that it represents one of the most important rehabilitation focus. Virtual reality is a fairly recent approach able to simulate concrete movements and functional tasks in a higher dosage compared to other therapies. It seems that the use of VR could improve limb function, however, the amount of this gain is still unclear because of insufficient evidence. This study aims at quantitatively investigating the effectiveness of an HMD immersive virtual reality system on the upper limb functioning in subacute stroke survivors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
2.1 years until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 25, 2025

Status Verified

November 1, 2024

Enrollment Period

2.8 years

First QC Date

January 30, 2023

Last Update Submit

March 17, 2025

Conditions

Keywords

strokerehabilitationupper limbimmersive virtual realityhead-mounted displaysubacute stroke

Outcome Measures

Primary Outcomes (1)

  • Changes in upper limb impairment

    Motor recovery will be assessed through the Fugl Meyer Assessment - Upper Extremity

    Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)

Secondary Outcomes (8)

  • Change in Spasticity

    Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)

  • Change in Activities of Daily Living

    Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)

  • Change in perceived quality of life

    Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)

  • Kinematic data

    Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment

  • Electroencephalogram

    Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)

  • +3 more secondary outcomes

Study Arms (2)

VR group

EXPERIMENTAL

All participants will receive an hour of VR training 5 times/week for 4 weeks within the daily rehab routine.

Device: Virtual Reality

Control group

NO INTERVENTION

Participants will receive the usual rehabilitation activities due to their clinical needs (physical therapy, speech therapy, etc) for 5 times/week over 4 weeks.

Interventions

Four tasks, uni and bi-manuals, will be proposed for the treatment of the patient's paretic upper limb in virtual-apartment for improving the relevance and the transferability of the movements requested.

Also known as: Head-mounted display
VR group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of first, ischemic or hemorrhagic, stroke verified by brain imaging within 4 week
  • upper limb motor impairment defined by an upper extremity score \<55 on the Fugl-Meyer Assessment

You may not qualify if:

  • neurological conditions in addition to stroke that may affect motor function
  • other medical conditions likely to interfere with the ability to safely complete the study protocol
  • impaired cognitive functioning that influences the ability to give informed consent
  • severe neuropsychological disorders
  • visual impairment
  • severe upper-limb pain defined as \> 7 on the Visual Analogue Scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ferrara University Hospital

Ferrara, 44124, Italy

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Smart Glasses

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and Supplies

Central Study Contacts

Sofia Straudi, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The randomization scheme will be generated using the website http://www.randomization.com and managed by an external administrator. The clinicians who will perform the outcome assessment will be blind regarding the subject's group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2023

First Posted

March 25, 2025

Study Start

March 1, 2023

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 25, 2025

Record last verified: 2024-11

Locations